The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 12th Sep 2016 09:24

(ShareCast News) - Autotrader: Barclays reiterates equal-weight with a target price of 375p.Hikma: Jefferies maintains buy with a 2500p target.Wood Group: Exane BNP Paribas upgrades to buy with a 815p target.Man Group: Citigroup upgrades to buy with a 137p target.McCarthy & Stone: Goldman Sachs keeps at buy with a target price of 227p.GlaxoSmithKline: HSBC maintains buy with a target price of 1970p.Rightmove: Barclays stays at underweight with a 3650p target.Astrazeneca: Jefferies upgrade s to buy with a target of 5800.Electra Private Equity: HSBC starts coverage at hold with a 4100p target.Rolls-Royce: Credit Suisse reiterates underperform with a 595p target.CYBG: JP Morgan stays at underweight with a 200p target.EnQuest: Canaccord reiterates hold, 30p target.

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.